Opinion
Mark Lister: The smart way to put a big payout to work in a jittery market
OPINION: Many Fonterra farmers may ponder how to best invest a windfall of up to $400,000.
Latest from Stock
Stories and analysis from The Northern Express Herald.
Mark Lister: Why markets tend to do fine no matter who wins in November
Shares have risen under every government since 1975, despite political shifts.
Greg Smith: Oil price whiplash – NZ's fuel and markets resilience tested
OPINION: New Zealand now holds only about four weeks of fuel in onshore storage.
How professional investors react when markets panic
Trending sectors can seem appealing in a crisis, but what do investment experts think?
Stock Takes: Reporting season reveals economic recovery winners and laggards
Tourism is the standout bright spot, while new-build construction still lags.
Stock Takes: Power giants tap $925m as investors back sector's growth story
Morningstar says Meridian is fairly valued with a forward dividend yield of 4%.
Stocks rise after court ruling against Trump tariffs
The Supreme Court decision could boost company earnings around the globe.
Greg Smith: What to look for in NZ company results this earnings season
OPINION: Why this earnings season matters more than the numbers.
Stock Takes: Investors brace for pivotal earnings season to show if recovery is real
Skellerup kicks off a packed February earnings calendar across key sectors.
Market close: Prices fall as inflation jump stokes interest rate hike fears
The S&P/NZX 50 Index slid 0.73% to close at 13,412.87 on a weak day.
These prophets of economic doom are worried about another collapse
Washington Post: The current investment boom is triggering deja vu for some economists.
Wall St bets on fourth year of gains as S&P 500 bull run rolls into 2026
All 21 Wall Street strategists surveyed tip the S&P 500 to rise in 2026.
Stock Takes: BlackRock still 'pro-risk' despite talk of AI bubble
BlackRock's unrelenting 'pro-risk' approach, and Vital management goes internal.
Market close: Retirement stocks rise on quiet day for NZ sharemarket
The NZX was up slightly with Ryman and Summerset benefiting from a lull.
Mark Lister: The upside of short-term sharemarket pain
OPINION: Nine market dips of 10% or more have occurred since 2010, lasting three months.
Stock Takes: Can the a2 Milk leopard change its spots?
Dual-listed a2 Milk is becoming an infant formula manufacturer in its own right.
Mark Lister: Why NZ's market isn't really at a record high
OPINION: When dividends are stripped out, the NZX 50 remains 13.9% below its 2021 peak.
Stock Takes: Could F&P Healthcare surprise with better than forecast result?
F&P Healthcare has forecast revenue of $1.075b and net profit of $200m for the half.
Markets slide as Nvidia test looms and Fed doubts grow
Nvidia shares fell 1.9% ahead of its earnings, testing investor confidence.
Why Xero shares are tumbling despite record profit, bullish outlook
The $4b elephant in the room, 'exhausted pricing power', slowing growth, an AI poser.
Stock Takes: Why this reporting season could signal a long-awaited economic rebound
About 20-odd companies are due to report results over the next few weeks.
Market close: NZ sharemarket dips ahead of Mainfreight and Infratil results
The NZ sharemarket closed marginally down on Tuesday as Mainfreight readies to report.
The Prosperity Project: Will the AI boom become a bubble?
An investment expert suggests we proceed with caution.
‘Continuation of concern’: AI-fuelled sell-off wipes US$1t from big tech
AI firms’ huge spending plans now face scrutiny over how profits will follow.
Stock Takes: Is a2 Milk on a roll again?
Shares in a2 Milk have rallied by about 77% so far this year.
Palantir plunges as Burry bets against AI rally
Michael Burry of The Big Short fame's firm disclosed short positions on Palantir, Nvidia.
Stock Takes: Wall Street's tech-fuelled rally stirs market bubble fears
ASB says at 18% above its 200-day average, the Nasdaq 100 is near bubble levels.
Stock Takes: Takeover battle brews for Comvita as founder mounts rival bid against rich-lister's investment company
Founder Alan Bougen is rallying investors to oppose the Florenz bid.
Generate Wealth Weekly: AI boom or bubble? Why this time may be different
AI firms now generate close to US$20b a year in measurable revenue.